Cargando…
β-Elemene treatment of glioblastoma: a single-center retrospective study
Glioblastoma (GBM) is the most common primary malignancy in the central nervous system. In this study, we investigated the therapeutic effects of β-elemene (ELE) treatment in patients with newly diagnosed GBM who received concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide. Our...
Autores principales: | Ma, Chunxiao, Zhou, Wei, Yan, Zhaoyue, Qu, Mingqi, Bu, Xingyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161392/ https://www.ncbi.nlm.nih.gov/pubmed/28003765 http://dx.doi.org/10.2147/OTT.S120854 |
Ejemplares similares
-
Toll-like Receptor 4 (TLR4) is Associated with Cerebral Vasospasm and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage
por: MA, Chunxiao, et al.
Publicado: (2015) -
The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma
por: Qu, Mingqi, et al.
Publicado: (2017) -
β-Elemene Triggers ROS-dependent Apoptosis in Glioblastoma Cells Through Suppressing STAT3 Signaling Pathway
por: Cai, Shi-zhong, et al.
Publicado: (2021) -
β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021) -
Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy
por: Zhai, Bingtao, et al.
Publicado: (2018)